Press Releases

The new leadership roles support the company’s momentum in becoming the leader in developing and commercializing therapeutics based on exploiting the lysosome to treat challenging solid tumors as well as chemotherapy-induced peripheral neuropathy (CIPN). FOR IMMEDIATE RELEASE [Covington, KY---February 2, 2022] Bexion Pharmaceuticals, a clinical stage biopharmaceutical company, today announced key leadership changes, including the appointment of Richard “Scott” Shively as the Company’s [...]

Covington, KY, December 23, 2021 – Bexion Pharmaceuticals, Inc, today announced that it is presenting virtually at the Biotech Showcase™ 2022 conference with an online presentation. This year, registered attendees to Biotech Showcase can access Bexion’s recorded company presentation beginning the week of December 6th – five weeks prior to the actual event. 24x7 on-demand access allows attendees to view presentations at their [...]

FOR IMMEDIATE RELEASE Covington, KY,  29 September 2021               Bexion Pharmaceuticals, Inc. announced today that a Study May Proceed letter has been received from the US Food and Drug Administration (FDA) for the Investigational New Drug Application (IND) for BXQ-350 to initiate a Phase 1b/2 clinical trial in newly diagnosed stage 4 metastatic colorectal cancer patients. Bexion recently completed Phase 1 studies in both [...]

FOR IMMEDIATE RELEASE [Covington, KY---September 17, 2021] Bexion Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, announced today that Gilles Tapolsky PhD, MBA, Bexion’s Vice President, Pharmacology will be virtually presenting preclinical and clinical data of the Company’s lead compound, BXQ-350.  The presentation will be made at the Discovery on Target (DOT) Conference in the Immunology and Oncology- Emerging Drug Targets Segment: BXQ-350: Stimulating the [...]

FOR IMMEDIATE RELEASE [Covington, KY---April 20, 2021] Bexion Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, announced today that an abstract submitted for an eTalk Session at the CIMT annual meeting to be held virtually May 10-12, 2021 has been chosen for presentation. Every year, the CIMT Annual Meeting connects the global cancer immunotherapy community in the heart of Europe. As the largest meeting focused [...]

Jupiter, FL— The award-winning series, Advancements with Ted Danson, will focus on an innovative, targeted approach to treating a range of diseases during 3Q/2021. Check local listings for more information. The diseases for which medicine offers few effective options – advanced cancer (or even early-stage cancer for certain types), neurodegenerative diseases and autoimmune diseases – persist because they involve very complex and interrelated cellular operations. Advancements will [...]